EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human respiratory syncytial virus genetic diversity and lineage replacement in Ireland pre- and post-COVID-19 pandemic

Alan Rice, Gabriel Gonzalez, Michael Carr, Jonathan Dean, Emer O'Byrne, Lynn Aarts, Harry Vennema, Weronika Banka, Charlene Bennett, Siobhán Cleary, Lisa Domegan, Joan O'Donnell und 9 weitere

Microbial Genomics · 2025

DOI: 10.1099/mgen.0.001379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Genomics, 2025. Verfasst von Alan Rice und 20 weiteren Autor:innen. Beteiligte Einrichtung: UCD National Virus Reference Laboratory, University College Dublin, Dublin, Belfield, D04 E1W1, Ireland. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus, Human, COVID-19, Respiratory Syncytial Virus Infections, Genetic Variation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Medicines Initiative, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human respiratory syncytial virus (HRSV) is a common cause of lower respiratory tract infections globally, and changes in viral epidemiology have been observed in many jurisdictions following the coronavirus disease 2019 (COVID-19) pandemic. Newly licensed vaccines and monoclonal antibodies are anticipated to alleviate the burden on healthcare systems, though such interventions may exert selective pressures on viral evolution. To evaluate the diversity of HRSV in Ireland pre- and post-COVID-19 pandemic, whole-genome sequencing was performed on HRSV-A ( n =123) and -B ( n =110) samples collected from community and hospitalized cases, during three HRSV seasons between 2021 and 2024. Additionally, G gene sequences, from HRSV-A ( n =141) and -B ( n =141), collected in the 2015–2019 period were examined. Lineages were assigned by phylogenetic analyses including reference lineages. Phylogenetic trees inferred with the G gene and whole genomes were consistent. Changes in the prevalence of certain lineages post-COVID-19 reflected the impact of non-pharmaceutical interventions (NPIs) introduced to reduce severe acute respiratory syndrome coronavirus 2 transmission, with A.D.1 and A.D.5 the dominant HRSV-A lineages and B.D.E.1 the most prevalent HRSV-B lineage. Similar trends were observed in HRSV lineages circulating across Europe during this time. The emergence of a new lineage was identified as a descendant from A.D.1, with eight distinctive substitutions in proteins G, F and L. Other circulating lineages with aa substitutions were observed in the F glycoprotein, which could impact nirsevimab binding. We provide the first comprehensive analysis of HRSV genomic diversity and evolution in Ireland over the last decade and the impact of the NPIs introduced during the COVID-19 pandemic. This study provides a foundation for future public health surveillance employing pathogen genomics to enable an evidence-based assessment of the impact of pharmaceutical interventions on HRSV evolution and disease severity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus, HumanCOVID-19Respiratory Syncytial Virus InfectionsGenetic VariationHumansIrelandPhylogenyGenome, ViralWhole Genome SequencingSARS-CoV-2Pandemics

Stichwörter der Autor:innen

genetic diversityhuman respiratory syncytial viruslineagesorthopneumoviruswhole-genome sequencing

Autor:innen und Institutionen

  • UCD National Virus Reference Laboratory, University College Dublin, Dublin, Belfield, D04 E1W1, Ireland.
  • Institute for Vaccine Research and Development, Hokkaido University, Sapporo, Hokkaido 001-0021, Japan.
  • International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Hokkaido 001-0020, Japan.
  • Centre for Infectious Disease Control, National Institute for Public Health and Environment, Bilthoven, Netherlands.
  • Health Protection Surveillance Centre, Dublin, Ireland.
  • Department of Laboratory Medicine and Pathology, University of Washington, Seattle, USA.

Förderung

  • Innovative Medicines Initiative
  • Japan Agency for Medical Research and Development

Zitieren

APA

Rice, A., Gonzalez, G., Carr, M., Dean, J., O'Byrne, E., Aarts, L., Vennema, H., Banka, W., Bennett, C., Cleary, S., Domegan, L., O'Donnell, J., O'Leary, M., Goya, S., Presser, L., Meijer, A., Martin, G., Sawa, H., Waters, A., …, & Hare, D. (2025). Human respiratory syncytial virus genetic diversity and lineage replacement in Ireland pre- and post-COVID-19 pandemic. Microbial Genomics. https://doi.org/10.1099/mgen.0.001379

Vancouver

Rice A, Gonzalez G, Carr M, Dean J, O'Byrne E, Aarts L, et al. Human respiratory syncytial virus genetic diversity and lineage replacement in Ireland pre- and post-COVID-19 pandemic. Microbial Genomics. 2025. doi:10.1099/mgen.0.001379

BibTeX
@article{Rice2025,
  author = {Rice, Alan and Gonzalez, Gabriel and Carr, Michael and Dean, Jonathan and O'Byrne, Emer and Aarts, Lynn and Vennema, Harry and Banka, Weronika and Bennett, Charlene and Cleary, Siobhán and Domegan, Lisa and O'Donnell, Joan and O'Leary, Maureen and Goya, Stephanie and Presser, Lance and Meijer, Adam and Martin, Greg and Sawa, Hirofumi and Waters, Allison and De Gascun, Cillian and Hare, Daniel},
  title = {Human respiratory syncytial virus genetic diversity and lineage replacement in Ireland pre- and post-COVID-19 pandemic},
  journal = {Microbial Genomics},
  year = {2025},
  doi = {10.1099/mgen.0.001379}
}
Kostenlos starten →